James H. Litinsky increased its stake in New York Times Co (NYT) by 9.46% based on its latest 2017Q4 regulatory filing with the SEC. Jhl Capital Group Llc bought 350,000 shares as the company’s stock rose 25.14% while stock markets declined. The hedge fund run by James H. Litinsky held 4.05M shares of the newspapers and magazines company at the end of 2017Q4, valued at $74.93 million, up from 3.70M at the end of the previous reported quarter. Jhl Capital Group Llc who had been investing in New York Times Co for a number of months, seems to be bullish on the $3.87B market cap company. The stock increased 0.43% or $0.1 during the last trading session, reaching $23.45. About 2.64M shares traded or 15.21% up from the average. The New York Times Company (NYSE:NYT) has risen 62.46% since May 18, 2017 and is uptrending. It has outperformed by 50.91% the S&P500.
James E. Flynn decreased its stake in Ardelyx Inc (ARDX) by 10.08% based on its latest 2017Q4 regulatory filing with the SEC. Deerfield Management Company sold 276,900 shares as the company’s stock declined 23.36% with the market. The hedge fund run by James E. Flynn held 2.47 million shares of the health care company at the end of 2017Q4, valued at $16.30M, down from 2.75M at the end of the previous reported quarter. Deerfield Management Company who had been investing in Ardelyx Inc for a number of months, seems to be less bullish one the $273.72 million market cap company. The stock increased 0.88% or $0.05 during the last trading session, reaching $5.75. About 100,704 shares traded. Ardelyx, Inc. (NASDAQ:ARDX) has declined 60.67% since May 18, 2017 and is downtrending. It has underperformed by 72.22% the S&P500.
Deerfield Management Company, which manages about $4.41B and $2.54 billion US Long portfolio, upped its stake in Lannet Inc (NYSE:LCI) by 1.26 million shares to 2.72 million shares, valued at $63.04 million in 2017Q4, according to the filing. It also increased its holding in Blueprint Medicines Corp by 193,000 shares in the quarter, for a total of 396,000 shares, and has risen its stake in Arena Pharmaceuticals Inc.
Among 7 analysts covering Ardelyx Inc (NASDAQ:ARDX), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Ardelyx Inc has $33 highest and $12.0 lowest target. $16.71’s average target is 190.61% above currents $5.75 stock price. Ardelyx Inc had 16 analyst reports since August 18, 2015 according to SRatingsIntel. JMP Securities maintained it with “Market Outperform” rating and $21 target in Wednesday, March 9 report. The firm has “Buy” rating by Cantor Fitzgerald given on Monday, August 28. The company was maintained on Thursday, October 12 by Wedbush. The firm has “Buy” rating given on Friday, December 18 by BTIG Research. The firm has “Buy” rating given on Thursday, September 3 by Wedbush. The stock of Ardelyx, Inc. (NASDAQ:ARDX) has “Buy” rating given on Friday, March 16 by Cantor Fitzgerald. The rating was initiated by BTIG Research on Tuesday, September 22 with “Buy”. As per Wednesday, August 9, the company rating was maintained by Cantor Fitzgerald. The rating was maintained by Citigroup on Wednesday, August 10 with “Buy”. The firm earned “Buy” rating on Friday, October 13 by BTIG Research.
Another recent and important Ardelyx, Inc. (NASDAQ:ARDX) news was published by Seekingalpha.com which published an article titled: “Ardelyx Looks Cheap But Not Without Risk” on May 17, 2018.
Analysts await Ardelyx, Inc. (NASDAQ:ARDX) to report earnings on August, 8. They expect $-0.46 EPS, up 14.81% or $0.08 from last year’s $-0.54 per share. After $-0.36 actual EPS reported by Ardelyx, Inc. for the previous quarter, Wall Street now forecasts 27.78% negative EPS growth.
Among 6 analysts covering New York Times (NYSE:NYT), 3 have Buy rating, 1 Sell and 2 Hold. Therefore 50% are positive. New York Times has $2700 highest and $7.80 lowest target. $18.28’s average target is -22.05% below currents $23.45 stock price. New York Times had 16 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, July 10 by Jefferies. TheStreet upgraded the shares of NYT in report on Tuesday, August 18 to “Buy” rating. As per Wednesday, July 19, the company rating was maintained by Barclays Capital. As per Monday, October 16, the company rating was maintained by Jefferies. The firm has “Overweight” rating by JP Morgan given on Monday, April 30. The stock of The New York Times Company (NYSE:NYT) earned “Hold” rating by FBR Capital on Thursday, August 6. The firm has “Hold” rating given on Monday, June 5 by Jefferies. The stock of The New York Times Company (NYSE:NYT) has “Hold” rating given on Monday, September 11 by Jefferies. The firm has “Buy” rating by J.P. Morgan given on Monday, April 30. The rating was maintained by Jefferies with “Hold” on Thursday, July 27.
More important recent The New York Times Company (NYSE:NYT) news were published by: Seekingalpha.com which released: “The New York Times’ (NYT) CEO Mark Thompson on Q1 2018 Results – Earnings Call Transcript” on May 06, 2018, also Forbes.com published article titled: “Why We Revised Our Price Estimate For New York Times To $21”, 247Wallst.com published: “New York Times Digital Growth Buoys Q1 Earnings” on May 03, 2018. More interesting news about The New York Times Company (NYSE:NYT) was released by: 247Wallst.com and their article: “JPMorgan Makes Huge Contrarian Call and Upgrades New York Times” with publication date: May 01, 2018.
Investors sentiment decreased to 1.44 in 2017 Q4. Its down 0.10, from 1.54 in 2017Q3. It fall, as 21 investors sold NYT shares while 52 reduced holdings. 38 funds opened positions while 67 raised stakes. 113.15 million shares or 3.98% more from 108.81 million shares in 2017Q3 were reported. Amg Funds Ltd, Connecticut-based fund reported 117,425 shares. Nordea Investment Management Ab reported 128,848 shares stake. Rhumbline Advisers holds 0.01% or 261,198 shares in its portfolio. Suntrust Banks Inc invested 0% in The New York Times Company (NYSE:NYT). Mason Street Ltd Limited Liability Company owns 62,020 shares for 0.03% of their portfolio. Commercial Bank Of America De owns 0% invested in The New York Times Company (NYSE:NYT) for 246,839 shares. Nine Masts Cap Ltd holds 290,000 shares. Jane Street Grp Inc Ltd Liability Com holds 0% in The New York Times Company (NYSE:NYT) or 80,663 shares. Grantham Mayo Van Otterloo & Lc accumulated 110,000 shares. Teacher Retirement Systems Of Texas holds 0.01% or 44,583 shares in its portfolio. Equitec Specialists Ltd Limited Liability Company holds 12,400 shares. Federated Invsts Pa accumulated 50,860 shares or 0% of the stock. Parametric Port Assocs Ltd Company owns 0.01% invested in The New York Times Company (NYSE:NYT) for 372,097 shares. Retirement Of Alabama stated it has 0.01% in The New York Times Company (NYSE:NYT). Moreover, Sg Americas Secs Lc has 0.01% invested in The New York Times Company (NYSE:NYT).